Thursday, December 07, 2017 2:16:18 AM
http://www.medivir.se/v5/en/RnD/proj_Remetinostat.cfm
Nick Taylor from FB wrote this a few months ago regard Remetinostat. I’m my opinion things are lining up and those attempting to screw retail stakeholders will end up very wealthy when TLOG’s former assets move forward.
“When Medivir bought the asset last year it predicted it could win approval with a phase 3 program of “modest size and cost,” but that it was unlikely to bring remetinostat to market before 2021.
If Medivir can execute that plan, it thinks a market worth $900 million in the U.S. will open up.”
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM